<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pregnancy loss (miscarriage): Terminology, risk factors, and etiology</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pregnancy loss (miscarriage): Terminology, risk factors, and etiology</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pregnancy loss (miscarriage): Terminology, risk factors, and etiology</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sarah Prager, MD, MAS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth Micks, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa K Dalton, MD, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert L Barbieri, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Courtney A Schreiber, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 02, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3971526498"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Pregnancy loss, also referred to as miscarriage or spontaneous abortion, is generally defined as a nonviable intrauterine pregnancy up to 20 weeks gestation. Early pregnancy loss, which occurs in the first trimester, is the most common type. The nonspecific symptoms of vaginal bleeding and uterine cramping associated with pregnancy loss can occur in normal, ectopic, and molar pregnancies, which can be a source of frustration for patients and clinical confusion for care providers.</p><p>This topic will review the terminology, risk factors, and etiology for pregnancy loss up to 20 weeks gestation. Related topics on clinical presentation of individuals with pregnancy loss, treatment options, and management protocols, as well as related content on vaginal bleeding in pregnancy, stillbirth at ≥20 weeks gestation, ectopic pregnancy, and molar pregnancy are presented separately.</p><p>Content specific to pregnancy loss:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5442.html" rel="external">"Pregnancy loss (miscarriage): Clinical presentations, diagnosis, and initial evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/130834.html" rel="external">"Pregnancy loss (miscarriage): Counseling and comparison of treatment options and discussion of related care"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/128965.html" rel="external">"Pregnancy loss (miscarriage): Description of management techniques"</a>.)</p><p></p><p>Content related to vaginal bleeding in pregnant individuals:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6799.html" rel="external">"Evaluation and differential diagnosis of vaginal bleeding before 20 weeks of gestation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6827.html" rel="external">"Stillbirth: Incidence, risk factors, etiology, and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5487.html" rel="external">"Ectopic pregnancy: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3243.html" rel="external">"Hydatidiform mole: Epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p>In this topic, we will use the term "patient" to describe genetic females. We recognize that not all people capable of pregnancy identify as female and we encourage the reader to consider the specific counseling needs of transgender men and gender nonbinary individuals.</p><p class="headingAnchor" id="H192728663"><span class="h1">TERMINOLOGY OF PREGNANCY LOSS</span></p><p class="headingAnchor" id="H1837881436"><span class="h2">Commonly used wording</span><span class="headingEndMark"> — </span>A variety of terms are used to describe nonviable pregnancies, which can lead to confusion for clinicians and patients. We take the following approach to terminology:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Abortion</strong> – This refers to pregnancy loss up to 20 weeks (sometimes called spontaneous abortion) <strong>or</strong> pregnancy termination at any gestational age.</p><p></p><p class="bulletIndent1">In common parlance, induced abortion is also used to indicate a pregnancy terminated without an intent to result in a live fetus. In this scenario, the use represents a procedure (medical or surgical) and not a diagnosis. (See  <a class="medical medical_review" href="/d/html/3313.html" rel="external">"Overview of pregnancy termination"</a>.)</p><p></p><p class="bulletIndent1">Terminology for induced abortions include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Medication abortion</strong> – This wording refers to abortion performed "primarily with medications, including <a class="drug drug_general" data-topicid="10263" href="/d/drug information/10263.html" rel="external">mifepristone</a>, <a class="drug drug_general" data-topicid="9657" href="/d/drug information/9657.html" rel="external">misoprostol</a>, and misoprostol-alone," regardless of the "setting, context, gestational duration, or legal status" [<a href="#rid1">1</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Procedural abortion</strong> – This wording refers to abortion performed "primarily with instrumentation, including uterine aspiration (manual or electric), dilation and curettage, dilation and evacuation, or dilation and extraction," regardless of the "setting, context, pregnancy duration, or legal status" [<a href="#rid1">1</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anembryonic pregnancy</strong> – Anembryonic pregnancy refers to a nonviable pregnancy with a gestational sac that does not contain a yolk sac or embryo [<a href="#rid2">2</a>]. This terminology includes pregnancies in which an embryo may have been present but has since been resorbed. Anembryonic pregnancy contrasts with "embryonic or fetal demise" in which an embryo or fetus is visualized but cardiac activity is not present.</p><p></p><p class="bulletIndent1">An anembryonic pregnancy may be diagnosed with highest diagnostic certainty when [<a href="#rid2">2,3</a>] (see  <a class="medical medical_review" href="/d/html/130879.html" rel="external">"Pregnancy loss (miscarriage): Ultrasound diagnosis"</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>There is no embryo seen on endovaginal scanning in a gestational sac with <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fradiopaedia.org%2Farticles%2Fmean-sac-diameter%3Flang%3Dus&amp;token=uPYADjSGzWKCyAavPPUVlj6SzGnPqveErO%2Fqx9PjZNyo8ApuymEqGuTTJfIIr5Rx6BGvHShXiPcWNTT4O00cjK8AtSQsFLDSFqHlsS1NKKs%3D&amp;TOPIC_ID=5439" target="_blank">mean sac diameter </a>≥25 mm <strong>or</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>There is no embryo on follow-up endovaginal scan</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>≥11 days after scan showing gestational sac with yolk sac, but no embryo, <strong>or</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>≥2 weeks after a scan showing gestational sac without yolk sac or embryo</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>First-trimester</strong> <strong>(early) pregnancy loss</strong> – Although there is no consensus regarding terminology, first-trimester, or early pregnancy loss (EPL), is described by several national organizations as a nonviable, intrauterine pregnancy within the first trimester (up to 12 6/7 weeks from the last menstrual period) [<a href="#rid4">4,5</a>]. However, at least one organization uses 10 0/7 weeks of gestational age as the cutoff, which can make study comparisons challenging [<a href="#rid6">6</a>]. EPL is broad terminology that includes pregnancies with an empty gestational sac (sometimes referred to as an anembryonic pregnancy) and pregnancies with an embryo or fetus without cardiac activity. The ultrasound criteria for diagnosis of pregnancy loss are presented in related content. (See  <a class="medical medical_review" href="/d/html/130879.html" rel="external">"Pregnancy loss (miscarriage): Ultrasound diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Embryonic demise</strong> – Embryonic demise is diagnosed with the highest diagnostic certainty when a pregnancy with a visible embryo ≥7 mm is without cardiac activity. This terminology applies to pregnancies measuring less than 10 weeks by ultrasound.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fetal demise</strong> – Fetal demise is used if a fetus (ie, pregnancy measuring 10 weeks of gestation or greater) without cardiac activity is visualized.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Miscarriage</strong> – Synonymous with pregnancy loss. Preferred terminology by patients in one survey study [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recurrent pregnancy loss</strong> – Recurrent pregnancy loss is defined as spontaneous loss of two or more pregnancies. (See  <a class="medical medical_review" href="/d/html/5437.html" rel="external">"Recurrent pregnancy loss: Definition and etiology"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Second-trimester pregnancy loss</strong> – Early second-trimester pregnancy loss is one that occurs after 13 0/7 and up to 19 6/7 weeks of gestation [<a href="#rid8">8</a>]. The 19 6/7 week cutoff for stillbirth is arbitrary and not related to any physiologic differences between pregnancies less than 20 weeks versus greater than 20 weeks [<a href="#rid9">9</a>]. By convention, nonviable pregnancies of 20 weeks gestation or more are typically referred to as stillbirth or fetal death.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Septic abortion (miscarriage)</strong> – Septic abortion refers to any abortion, spontaneous or induced, that is complicated by uterine infection. (See  <a class="medical medical_review" href="/d/html/130878.html" rel="external">"Septic abortion: Clinical presentation and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stillbirth or fetal death</strong> – Pregnancy loss that occurs at 20 0/7 weeks gestation or later, or at a weight of 350 grams or greater, is generally referred to as a stillbirth or fetal death, although differing criteria exist globally [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/d/html/6827.html" rel="external">"Stillbirth: Incidence, risk factors, etiology, and prevention", section on 'Definitions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonspecific terminology</strong> – The terms below are historical and, in part, reflect the development and subsequently improved accuracy of ultrasound technology. We do not use these phrases as they are not clearly standardized, do not always convey the information required for clinical decision-making, and have contributed to patient confusion, particularly if used interchangeably.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Blighted ovum</strong> – Blighted ovum is a historical phrase that is no longer preferred and has been replaced by "anembryonic pregnancy," as discussed above. Nonviability can result from multiple causes, not just the ovum.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Incomplete miscarriage</strong> – "Incomplete miscarriage" and "incomplete abortion" are historical terms typically used to indicate that there is persistent pregnancy tissue in the uterus after a diagnosis of pregnancy loss. Other wording that is more specific is preferred; one example is "persistent empty gestational sac despite initial diagnosis of nonviability (insert number of weeks) weeks ago."</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Inevitable miscarriage</strong> – Inevitable miscarriage or abortion has been used to describe a miscarriage that cannot be avoided because the cervix is open, bleeding is heavy or increasing, and abdominal cramping is present. However, it can be difficult to differentiate between an open external or internal cervical os, particularly in parous individuals, and this phrase is no longer preferred.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Missed abortion</strong> – "Missed abortion" has been used to describe a nonviable pregnancy in the absence of symptoms. These individuals are now described as having asymptomatic pregnancy loss. (See  <a class="medical medical_review" href="/d/html/5442.html" rel="external">"Pregnancy loss (miscarriage): Clinical presentations, diagnosis, and initial evaluation", section on 'Asymptomatic or incidental'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Threatened miscarriage</strong> – "Threatened miscarriage" or "threatened abortion" has been used in reference to a patient experiencing bleeding in early pregnancy but without a clear diagnosis of pregnancy loss. We find this definition imprecise and more accurately conveyed as bleeding in early pregnancy.</p><p></p><p class="headingAnchor" id="H214860335"><span class="h2">Language preferred by patients</span><span class="headingEndMark"> — </span>In a study of 145 United States English-speaking patients being treated for first-trimester pregnancy loss, patients preferred the terms "miscarriage" and "early pregnancy loss" rather than "early pregnancy failure" or "spontaneous abortion," which they believed to be less clear [<a href="#rid7">7</a>]. It is unclear how primary spoken language and culture influence terminology preference.</p><p class="headingAnchor" id="H1365483668"><span class="h2">Terminology versus billing codes</span><span class="headingEndMark"> — </span>Continued use of imprecise terminology is problematic because available codes are not easily aligned with the clinically relevant pregnancy loss categories in use. Since these billing codes are generally required to document a clinical encounter in an electronic medical record, it is often impossible to document the relevant subcategory of pregnancy loss, making quality monitoring or other evaluation activities difficult  (<a class="graphic graphic_table graphicRef120361" href="/d/graphic/120361.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H1380130289"><span class="h1">INCIDENCE</span><span class="headingEndMark"> — </span>Pregnancy loss is the most common complication in early pregnancy.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>First trimester</strong> – The incidence of early pregnancy loss (EPL) has been estimated to be high as 31 percent by logistic regression, though that incidence decreases to approximately 10 percent when considering only losses occurring in clinically recognized pregnancies [<a href="#rid11">11,12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Second trimester</strong> – The incidence of second-trimester loss up to 20 weeks gestation is less than 1 percent [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Data limitations</strong> – The true incidence of pregnancy loss is difficult to ascertain as many losses occur prior to clinically recognized pregnancy. We think about pregnancy loss as occurring at two different time points: after implantation but before clinical recognition or after clinical recognition (defined as diagnosed by a clinician or by standard pregnancy testing) [<a href="#rid12">12</a>]. A fertilized egg that does not implant is technically not a pregnancy, per accepted medical definitions of pregnancy. (See  <a class="medical medical_review" href="/d/html/440.html" rel="external">"Clinical manifestations and diagnosis of early pregnancy", section on 'Diagnosis'</a>.)</p><p></p><p class="headingAnchor" id="H3842869006"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>Common risk factors for pregnancy loss include increasing maternal age, medical conditions, medication and/or substance use, and environmental exposures.</p><p class="headingAnchor" id="H1545325563"><span class="h2">Maternal age and genetic anomaly</span><span class="headingEndMark"> — </span>Extremes of age increase the risk of pregnancy loss, with age &gt;35 years being the most significant risk factor because of the strong association with fetal chromosomal abnormalities  (<a class="graphic graphic_table graphicRef75423" href="/d/graphic/75423.html" rel="external">table 2</a>) [<a href="#rid11">11,14</a>]. In a national prospective cohort study of over 421,000 pregnancies, the risk of miscarriage (after excluding induced abortions) was lowest (10 percent) in individuals age 25 to 29 years and rose to a high of 57 percent for people age ≥45 years [<a href="#rid11">11</a>]. The early pregnancy loss rates by other age subgroups were 17 percent (&lt;20 years), 11 percent (20 to 24 years), 11 percent (30 to 34 years), 17 percent (35 to 39 years), and 33 percent (40 to 44 years).</p><p>While the impact of increasing paternal age is somewhat less clear, pregnancy loss risk does appear to rise with increasing paternal age  (<a class="graphic graphic_figure graphicRef120357" href="/d/graphic/120357.html" rel="external">figure 1</a>) [<a href="#rid15">15</a>]. These issues are presented in greater detail separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/421.html" rel="external">"Effects of advanced maternal age on pregnancy", section on 'Early pregnancy issues'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/415.html" rel="external">"Effect of advanced paternal age on fertility and pregnancy"</a>.)</p><p></p><p class="headingAnchor" id="H2553884229"><span class="h2">Prior pregnancy loss</span><span class="headingEndMark"> — </span>Prior pregnancy loss also increases the risk of subsequent pregnancy loss, independent of maternal age. In the above prospective cohort study of over 421,000 pregnancies, after adjusting for maternal age, the risk of miscarriage increased among those whose prior pregnancy ended in a miscarriage (adjusted odds ratios [OR] of miscarriage for one prior miscarriage: 1.54, 95% CI 1.48-1.60; two prior miscarriages: 2.21, 95% CI 2.03-2.41; three prior miscarriages: 3.97, 95% CI 3.29-4.78) [<a href="#rid11">11</a>]. In addition, at least one study has reported that patients who experienced pregnancy loss were more likely to have a mother who also had a history of pregnancy loss, which suggests a potentially inheritable component [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H1929151007"><span class="h2">Medical conditions in parents</span></p><p class="headingAnchor" id="H3157711394"><span class="h3">Maternal</span><span class="headingEndMark"> — </span>Various causes of maternal morbidity, such as endocrinopathies, cardiovascular disease, and metabolic disorders, are associated with pregnancy loss [<a href="#rid17">17</a>]. These may also be considered modifiable risk factors, as well-controlled maternal conditions are far less likely to result in loss. While any medical condition that negatively impacts maternal health can have potential reproductive consequences, some of the more common conditions that increase the risk of pregnancy loss are discussed below.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infection</strong> – Bacterial, protozoan, and viral infectious agents have been associated with increased risk of miscarriage; the exact mechanisms are not fully known [<a href="#rid18">18</a>]. Untreated syphilis leads to a 21 percent increased risk of fetal loss and stillbirth [<a href="#rid19">19</a>]. As compared with uninfected pregnant individuals, maternal viral infections have been associated with fetal loss rates nearly 8 percent for parvovirus B19, nearly 6 percent for Zika virus, and 2.5 percent for cytomegalovirus [<a href="#rid20">20-22</a>]. However, maternal infection with HIV or toxoplasmosis does not appear to be associated with an increased risk of pregnancy loss [<a href="#rid23">23,24</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/4794.html" rel="external">"Syphilis in pregnancy"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/8281.html" rel="external">"Parvovirus B19 infection during pregnancy"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/107211.html" rel="external">"Zika virus infection: Evaluation and management of pregnant patients", section on 'Potential consequences of vertical transmission'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/4810.html" rel="external">"Cytomegalovirus infection in pregnancy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diabetes</strong> – The effects of type 1 and 2 diabetes on early pregnancy can be extreme, even resulting in lethal fetal anomalies or pregnancy loss. Euglycemia in the preconception and periconception time periods brings this risk back to baseline. (See  <a class="medical medical_review" href="/d/html/94859.html" rel="external">"Pregestational (preexisting) diabetes: Preconception counseling, evaluation, and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obesity</strong> – Obesity is more strongly and consistently associated with pregnancy loss than either type 1 or 2 diabetes. A 2008 meta-analysis of 16 studies demonstrated that a body mass index greater than 25 was associated with a nearly 70 percent increased odds of pregnancy loss up to 20 weeks gestation after spontaneous or assisted conception (OR 1.67, 95% CI 1.25-2.25) [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/d/html/433.html" rel="external">"Obesity in pregnancy: Complications and maternal management", section on 'Early pregnancy loss'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thyroid disease</strong> – Both hyper- and hypothyroidism have been associated with increased risk of pregnancy loss, with at least one study reporting a doubling of risk [<a href="#rid26">26</a>]. These topics are covered in detail elsewhere.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/16609.html" rel="external">"Hypothyroidism during pregnancy: Clinical manifestations, diagnosis, and treatment", section on 'Pregnancy complications'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/7868.html" rel="external">"Hyperthyroidism during pregnancy: Clinical manifestations, diagnosis, and causes", section on 'Pregnancy complications'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stress</strong> – Both acute and chronic stress can increase the risk of pregnancy loss [<a href="#rid27">27,28</a>]. Stress is multifactorial and can be difficult to separate out from other risks. Chronic stress can lead to increased cortisol levels, decreased immunity, and may increase susceptibility to infection and other maternal conditions, all of which can then increase the risk of pregnancy loss [<a href="#rid29">29-33</a>]. If a person has an otherwise stable life, a short period of stress, such as a busy time at work or acute illness in a loved one, is unlikely to have a major impact. However, racial/ethnic, financial or other disparities, risk of violence, significant periods of housing or food insecurity in the past or present, or other long-term life stressors can negatively impact health in many ways, including increasing the risk of pregnancy loss [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Inherited thrombophilias</strong> – The effect of inheritable thrombophilias on pregnancy loss risk is unclear as the body of evidence conflicts. The available data are covered in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/4792.html" rel="external">"Inherited thrombophilias in pregnancy", section on 'Adverse pregnancy outcome risk'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy with intrauterine device (IUD) in place</strong> – While IUDs are some of the most effective contraceptive methods, device failures do occur. Though pregnancy with an IUD in place is relatively rare, for those patients who choose to continue their pregnancies, the risk of pregnancy loss appears to be higher for individuals who elect to leave the IUD in place rather than have it removed [<a href="#rid34">34</a>]. These issues are presented in greater detail in a related topic. (See  <a class="medical medical_review" href="/d/html/5422.html" rel="external">"Intrauterine contraception: Management of side effects and complications"</a> and  <a class="medical medical_review" href="/d/html/5422.html" rel="external">"Intrauterine contraception: Management of side effects and complications", section on 'Pregnancy'</a>.)</p><p></p><p class="headingAnchor" id="H3552702674"><span class="h3">Paternal</span><span class="headingEndMark"> — </span>After controlling for maternal age and medical comorbidities, preconception paternal medical conditions may modestly increase the risk of pregnancy loss. In a retrospective cohort study of an insurance database covering 958,804 pregnancies in the United States, compared with men with no components of metabolic syndrome (MetS), the risk of pregnancy loss increased for men with one (relative risk [RR] 1.10, 95% CI 1.09-1.12), two (RR 1.15, 95% CI 1.13-1.17), or three or more (RR 1.19, 95% CI 1.14-1.24) MetS components after stratifying for maternal and paternal age [<a href="#rid35">35</a>].</p><p class="headingAnchor" id="H659508763"><span class="h2">Medications and drug exposure</span></p><p class="headingAnchor" id="H1485818253"><span class="h3">Medication</span><span class="headingEndMark"> — </span>Information regarding the impact of specific drugs on the risk of miscarriage is available at the United States National Library of Medicine <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK501922%2F&amp;token=wEsKVFvqlKzpT%2BqOtddW%2Fy3%2BLj0shalBW%2BL1ZyL4trystKLNkAhaR%2FcduMJFFebszM73aaFBm717nqYa%2FpVDsg%3D%3D&amp;TOPIC_ID=5439" target="_blank">Drugs and Lactation Database</a>. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Challenges of risk assessment</strong> – The role of medication and substance use on pregnancy loss risk is challenging to assess as the impact varies by agent, dose, and timing of exposure. Numerous therapeutic medications are considered teratogenic in pregnancy, and some teratogenic effects can also result in an increased risk of pregnancy loss. Alternately, medications may be associated with pregnancy loss even in the absence of teratogenicity. As an example of the complicated nature of medication and risk of pregnancy loss, the nonsteroidal anti-inflammatory drugs (NSAIDs) <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> and <a class="drug drug_general" data-topicid="8559" href="/d/drug information/8559.html" rel="external">indomethacin</a> are used for specific obstetric indications (preeclampsia prevention and treatment of acute preterm labor) while other NSAIDs, including <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a> and <a class="drug drug_general" data-topicid="9348" href="/d/drug information/9348.html" rel="external">diclofenac</a>, may increase risk of pregnancy loss [<a href="#rid36">36,37</a>]. (See  <a class="medical medical_review" href="/d/html/7998.html" rel="external">"Safety of rheumatic disease medication use during pregnancy and lactation", section on 'NSAIDs'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Psychiatric medications</strong> – Psychiatric drugs, including antidepressants and antipsychotics, are presumed to cross the placenta. The impact by drug group is presented in related content. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/89067.html" rel="external">"Antenatal use of antidepressants and the potential risk of teratogenicity and adverse pregnancy outcomes: Selective serotonin reuptake inhibitors"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/17159.html" rel="external">"Teratogenicity, pregnancy complications, and postnatal risks of antipsychotics, benzodiazepines, lithium, and electroconvulsive therapy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>COVID-19 vaccine</strong> – Receipt of an mRNA COVID-19 vaccine either before conception or during pregnancy does not appear to increase the risk of pregnancy loss [<a href="#rid38">38-41</a>]. (See  <a class="medical medical_review" href="/d/html/127535.html" rel="external">"COVID-19: Overview of pregnancy issues", section on 'Vaccination in people planning pregnancy and pregnant or recently pregnant people'</a>.) </p><p></p><p class="headingAnchor" id="H2351761124"><span class="h3">Substance use</span><span class="headingEndMark"> — </span>In general, smoking, caffeine, and alcohol consumption appear to increase the risk of pregnancy loss in a dose-related fashion [<a href="#rid42">42-48</a>]. However, studies of substance use during pregnancy are almost always confounded with other factors that lead to poor health status and increased risk of pregnancy loss, and thus it is difficult to assess the independent impact of the drug(s) in epidemiologic studies. To significantly reduce the risks of confounding and reverse causality, a Mendelian-randomization study that used genetic variants associated with smoking initiation confirmed a 30 percent increased risk of pregnancy loss per standard deviation increase in the prevalence of smoking initiation (odds ratio 1.31, 95% CI 1.25-1.37) [<a href="#rid49">49</a>]. Significant associations were not reported for caffeine or alcohol consumption, showing them to be likely confounders and not causally related. The use of non-modifiable genetic data strengthens the causal association of smoking and pregnancy loss. </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4803.html" rel="external">"Cigarette and tobacco products in pregnancy: Impact on pregnancy and the neonate", section on 'Pregnancy loss (miscarriage)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/406.html" rel="external">"Caffeine: Effects on reproductive outcomes in females", section on 'Pregnancy loss (miscarriage)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4798.html" rel="external">"Alcohol intake and pregnancy", section on 'Perinatal outcomes'</a>.)</p><p></p><p>Some studies have reported increased risks with exposure to cocaine or methamphetamines [<a href="#rid45">45</a>]. Marijuana use in pregnancy does not appear to increase the risk of pregnancy loss, although it does negatively impact neonatal development [<a href="#rid50">50</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4799.html" rel="external">"Substance use during pregnancy: Screening and prenatal care"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/128152.html" rel="external">"Substance use during pregnancy: Overview of selected drugs"</a>.)</p><p></p><p class="headingAnchor" id="H1823922531"><span class="h2">Environmental factors and exposures</span><span class="headingEndMark"> — </span>Exposure to toxins and pollutants and other environmental factors may increase the risk of pregnancy loss by causing cell death, altering growth of normal tissues, or interfering with normal cellular differentiation or other processes. Exposure to ionizing radiation is definitively associated with pregnancy loss [<a href="#rid51">51</a>], while excessive lead, arsenic, and air pollution exposure appear to increase the risk. Some of these exposures can be avoided, but many occur where one lives or works and may not be avoidable. The role of specific agents and their impact on reproductive outcomes are discussed in more detail in related topics.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5447.html" rel="external">"Overview of occupational and environmental risks to reproduction in females"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/111468.html" rel="external">"Occupational and environmental risks to reproduction in females: Specific exposures and impact"</a>.)</p><p></p><p>In addition, work type or schedule (eg, night time shift work) may increase risk of pregnancy loss [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/d/html/439.html" rel="external">"Working during pregnancy"</a>.)</p><p class="headingAnchor" id="H3153621658"><span class="h2">Race and ethnicity</span><span class="headingEndMark"> — </span>Studies have consistently reported an increased risk of pregnancy loss in Black, Indigenous, and other people of color compared with White persons [<a href="#rid53">53,54</a>]. As an example, one prospective cohort study reported pregnancy loss between 10 and 20 weeks was nearly twice as common among Black American women compared with White American women (adjusted hazard ratio 1.57, 95% CI 1.27-1.93) [<a href="#rid53">53</a>]. However, this difference more likely reflects the impact of the cumulative stressors of systemic racism, social determinants of health, and unavoidable occupational and/or environmental exposure to potential toxins than a true biologic difference. (See  <a class="medical medical_review" href="/d/html/117408.html" rel="external">"Racial and ethnic inequities in obstetric and gynecologic care and role of implicit biases", section on 'Examples of inequities in reproductive health'</a>.)</p><p class="headingAnchor" id="H3481705983"><span class="h2">Subchorionic hematoma</span><span class="headingEndMark"> — </span>Subchorionic hemorrhage or hematoma is associated with increased risk of pregnancy loss, particularly when it amounts to 25 percent or more of the volume of the gestational sac  (<a class="graphic graphic_diagnosticimage graphicRef76333 graphicRef64570" href="/d/graphic/76333.html" rel="external">image 1A-B</a>) [<a href="#rid55">55</a>]. In a meta-analysis of seven comparative studies, pregnant individuals with subchorionic hematoma had double the odds of pregnancy loss compared with those without (18 versus 9 percent, OR 2.18, 95% CI 1.29-3.68) [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H3186850212"><span class="h1">RISK REDUCTION</span><span class="headingEndMark"> — </span>Multiple agents have been studied to reduce the risk of miscarriage.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Not helpful</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Prenatal vitamins</strong> – A meta-analysis of over 40 studies concluded that use of prenatal vitamins in the preconception, periconception, and early pregnancy time frames does not prevent early pregnancy loss [<a href="#rid57">57</a>]. It is unclear if <a class="drug drug_general" data-topicid="8475" href="/d/drug information/8475.html" rel="external">folic acid</a> specifically can reduce the risk of miscarriage, though supplementation does appear to reduce the risk compared with no supplementation [<a href="#rid58">58,59</a>], and multivitamins plus iron and folic acid have been associated with a reduced risk for stillbirth [<a href="#rid57">57</a>]. (See  <a class="medical medical_review" href="/d/html/453.html" rel="external">"Nutrition in pregnancy: Dietary requirements and supplements", section on 'Micronutrients'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9817" href="/d/drug information/9817.html" rel="external">Progesterone</a><strong> supplementation</strong> – Progesterone supplementation for patients with first-trimester vaginal bleeding has not been associated with increased live birth rates and is not advised for routine use [<a href="#rid60">60-62</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Helpful in some individuals</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Low-dose </strong><a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> – Low-dose aspirin (81 mg) was associated with reduced risk of pregnancy loss in one study of patients with one to two prior pregnancy losses [<a href="#rid63">63</a>]. While low-dose aspirin may have a role for patients with prior loss, it is not advised for routine use in individuals who have never been pregnant or not experienced miscarriage. A detailed discussion of the study and the authors approach is presented in related content. (See  <a class="medical medical_review" href="/d/html/130834.html" rel="external">"Pregnancy loss (miscarriage): Counseling and comparison of treatment options and discussion of related care", section on 'Role of low-dose aspirin to reduce risk of pregnancy loss'</a>.)</p><p></p><p>Patients with recurrent miscarriage, defined as two to three prior losses, are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/5444.html" rel="external">"Recurrent pregnancy loss: Management"</a>.)</p><p class="headingAnchor" id="H2817826386"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>Common etiologies of pregnancy loss at any gestational age include chromosomal abnormalities, maternal anatomic abnormalities, and trauma. For individuals with second-trimester loss, additional possible etiologies must be considered.</p><p class="headingAnchor" id="H3215606204"><span class="h2">Chromosomal abnormalities</span><span class="headingEndMark"> — </span>Chromosomal abnormalities, including aneuploidy, partial deletion, or duplication, are present in up to 70 percent of pregnancy losses before 20 weeks, though the prevalence varies by gestational age [<a href="#rid64">64-69</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact of gestational age at loss</strong> – In a study that evaluated 80 patients with pregnancy loss at &lt;20 weeks gestation with chromosomal microarray analysis, genetic abnormalities were reported in 9 percent of pre-embryonic losses (from implantation to less than 6 weeks), 69 percent of embryos between 6 0/7 weeks and 9 6/7 weeks, and 33 percent of fetuses between 10 0/7 weeks and 19 6/7 weeks [<a href="#rid66">66</a>]. The use of chromosomal microarray likely increased the ability to identify chromosomal abnormalities in earlier preclinical losses that previously were undetected by karyotype. This study challenged historic teaching that earlier gestational age was associated with increased risk of chromosomal abnormality. While embryonic losses are still more likely to result from chromosomal abnormalities compared with later fetal losses, this relationship does not appear to be valid for pre-embryonic losses (defined as no visible embryo on ultrasound evaluation). (See  <a class="medical medical_review" href="/d/html/16683.html" rel="external">"Prenatal diagnosis of chromosomal imbalance: Chromosomal microarray"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overall frequency of aneuploidy</strong> – In a study of 1000 consecutive patients age ≥18 years with pregnancy loss up to 22 weeks, evaluation of fetal ploidy status using cell-free fetal DNA (cffDNA) reported 45 percent euploid, 41 percent aneuploid, 4 percent with multiple aneuploidies, and 11 percent inconclusive [<a href="#rid70">70</a>]. Use of cffDNA to test patients with pregnancy loss is investigational and not routinely performed but presents a promising use of this technology. </p><p></p><p class="headingAnchor" id="H172924779"><span class="h2">Maternal anatomic anomalies</span><span class="headingEndMark"> — </span>Anatomic anomalies, such as uterine leiomyomas (fibroids), polyps, adhesions, or septa, may be associated with pregnancy loss based on their size and position in relation to the developing pregnancy. These may not be identified prior to experiencing pregnancy loss but, once diagnosed, can often be surgically or medically addressed before another pregnancy is attempted.</p><p>While not all studies support fibroids as contributing factors to pregnancy loss, different study populations may be one factor contributing to discrepant outcomes (recurrent pregnancy loss versus routine obstetric patients). The impact of fibroids on pregnancy loss likely varies by other clinical aspects as well, such as distortion of the uterine cavity and/or blood supply. (See  <a class="medical medical_review" href="/d/html/6801.html" rel="external">"Uterine fibroids (leiomyomas): Issues in pregnancy", section on 'Early pregnancy loss'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 104 women with recurrent pregnancy loss of multiple types, the most common structural diagnoses that likely contributed to the loss were intrauterine adhesions (15 percent), fibroids (14 percent), uterine septum (3 percent), and endometrial polyps (2 percent) [<a href="#rid71">71</a>]. For intrauterine adhesions, the number of adhesions was not reported. No diagnosis was identified in 18 percent of patients.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A 2017 meta-analysis of five studies including over 21,000 routine obstetric patients reported no association between uterine leiomyomas and pregnancy loss [<a href="#rid72">72</a>].</p><p></p><p class="headingAnchor" id="H2857917049"><span class="h2">Trauma</span><span class="headingEndMark"> — </span>Significant trauma can cause pregnancy loss. While the developing embryo is relatively protected within the uterus in early pregnancy, trauma that results in direct impact to the uterus can cause pregnancy loss. This can be due to violent trauma (gunshot wounds, penetrating injuries) or iatrogenic trauma, as with chorionic villus sampling and amniocentesis. (See  <a class="medical medical_review" href="/d/html/449.html" rel="external">"Chorionic villus sampling"</a>.)</p><p>A history of intimate partner violence (IPV) is consistently associated with higher incidence of pregnancy loss [<a href="#rid73">73,74</a>], though the data on IPV directly resulting in pregnancy loss are more mixed [<a href="#rid75">75,76</a>]. The association may be attributable to physical violence, psychological harm, or a combination of factors, both known and unknown. (See  <a class="medical medical_review" href="/d/html/15294.html" rel="external">"Intimate partner violence: Diagnosis and screening"</a> and  <a class="medical medical_review" href="/d/html/2789.html" rel="external">"Intimate partner violence: Epidemiology and health consequences"</a>.)</p><p class="headingAnchor" id="H48891376"><span class="h2">Specific to second-trimester loss</span><span class="headingEndMark"> — </span>Individuals experiencing second-trimester pregnancy loss are a heterogeneous group, and the underlying pathology overlaps with obstetric complications such as preterm delivery and preterm premature rupture of membranes. Frequently, second-trimester pregnancy loss has more than one cause, and often no etiology is identified [<a href="#rid77">77</a>].</p><p class="bulletIndent1">Known and suspected etiologies of second-trimester pregnancy loss include [<a href="#rid77">77</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Infection, including chorioamnionitis and maternal viral infection [<a href="#rid78">78</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Chronic stressors, including contributions from racial/ethnic, financial or other disparities, chronic food or housing insecurity, and other long-term life stressors [<a href="#rid29">29</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Uterine malformation</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cervical insufficiency</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fetal malformation or syndromes such as anencephaly, trisomies, renal agenesis, or hydrops</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Thrombophilias</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Abruption</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Premature preterm rupture of membranes</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Preterm labor</p><p></p><p class="headingAnchor" id="H2640451937"><span class="h1">RESOURCES FOR PATIENTS AND CLINICIANS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Planned Parenthood – <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.plannedparenthood.org%2Flearn%2Fpregnancy%2Fmiscarriage%2Fhow-do-i-know-if-im-having-miscarriage&amp;token=15ElnSJN69riKGiQekEtQJQehiNPzwRur3sMj4qm6OaqnL4TrmeGzdKgAjuBRl7mxBtRL2so87rU5MDHoVUxfWJ88OE%2BzTwVGp6tITjNZ%2BE9f%2FKS1Py%2Bi1kpRuzYebH1&amp;TOPIC_ID=5439" target="_blank">How do I know if I am having a miscarriage?</a></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>American College of Obstetricians and Gynecologists – FAQ <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.acog.org%2Fpatient-resources%2Ffaqs%2Fpregnancy%2Fearly-pregnancy-loss&amp;token=gDbSnwmeHsCz48hcsdRof6uSJ5Z0v2XuwpMClxamgPt%2B6iUXogKE8KvnGLzXqrh8OfTm1UXA3EiU8gDjmQMwgfRitAlGOF%2Bsl6JNg5id%2FHY%3D&amp;TOPIC_ID=5439" target="_blank">Early Pregnancy Loss</a></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Royal College of Obstetricians &amp; Gynaecologists – <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.rcog.org.uk%2Fglobalassets%2Fdocuments%2Fpatients%2Fpatient-information-leaflets%2Fpregnancy%2Fpi-early-miscarriage.pdf&amp;token=pw6NqvdyDNwQ3I2DQAEcb6MiU%2F5D0CoDZiI771twct5toOH%2BIC7rjNHmhQBi%2BROSyp5t%2B5LD0xL4kol3bac08eYBcdWtvIpB7ns89po6gGj8%2Bp0rO%2BobqKMZr6GaUb%2FbrwC1JCwUsNIWoeWxLU0oqw%3D%3D&amp;TOPIC_ID=5439" target="_blank">Early miscarriage</a></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Early pregnancy loss resources – An <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.earlypregnancylossresources.org%2F&amp;token=yg3nprUA5eADoEehxhWbpqSm5nkbbqdFvYMyMDL2M39KP2WeYRsQI0gyM3RTnp9vgKQhJhYLNiKNJBKOMs06nQ%3D%3D&amp;TOPIC_ID=5439" target="_blank">educational resource</a> for both clinicians and patients supported by a grant through the University of California San Francisco</p><p></p><p class="headingAnchor" id="H2999832111"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/114412.html" rel="external">"Society guideline links: Pregnancy loss (spontaneous abortion)"</a>.)</p><p class="headingAnchor" id="H1153263506"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15610.html" rel="external">"Patient education: Pregnancy loss (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/139726.html" rel="external">"Patient education: Coping after pregnancy loss (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/17047.html" rel="external">"Patient education: Bleeding in early pregnancy (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/6724.html" rel="external">"Patient education: Pregnancy loss (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H164909328"><span class="h1">PATIENT PERSPECTIVE TOPIC</span><span class="headingEndMark"> — </span>Patient perspectives are provided for selected disorders to help clinicians better understand the patient experience and patient concerns. These narratives may offer insights into patient values and preferences not included in other UpToDate topics. (See  <a class="medical medical_review" href="/d/html/132376.html" rel="external">"Patient perspective: Pregnancy loss"</a>.)</p><p class="headingAnchor" id="H1314293314"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology</strong> – A variety of terms are used to describe nonviable pregnancies, which can lead to confusion for clinicians and patients. Although there is no consensus regarding terminology, we prefer the terms "early pregnancy loss" (EPL) for nonviable, intrauterine pregnancies within the first trimester (up to 12 6/7 weeks from the last menstrual period) and "pregnancy loss" for any non-viable pregnancy up to 20 weeks gestation. (See <a class="local">'Terminology of pregnancy loss'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incidence</strong> – Pregnancy loss is the most common complication in early pregnancy. The incidence of first-trimester pregnancy loss is as high as 31 percent, though that incidence decreases to approximately 10 percent when considering only losses occurring in clinically recognized pregnancies. (See <a class="local">'Incidence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Common risk factors for pregnancy loss include increasing maternal age, prior pregnancy loss, medical conditions, medication and/or substance use, and environmental exposures. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk reduction</strong> – While prenatal vitamins and <a class="drug drug_general" data-topicid="9817" href="/d/drug information/9817.html" rel="external">progesterone</a> supplementation have not been shown to reduce risk of pregnancy loss, low-dose <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> (81 mg) may be helpful in individuals with one to two prior pregnancy losses. (See <a class="local">'Risk reduction'</a> above and  <a class="medical medical_review" href="/d/html/130834.html" rel="external">"Pregnancy loss (miscarriage): Counseling and comparison of treatment options and discussion of related care", section on 'Role of low-dose aspirin to reduce risk of pregnancy loss'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiologies</strong> – Etiologies common to pregnancy loss of any gestational age include chromosomal abnormalities, maternal anatomic abnormalities, and trauma. Individuals with second-trimester loss are a heterogeneous group and additional possible etiologies must be considered. (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="headingAnchor" id="H1884832660"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Togas Tulandi, MD, MHCM, and Haya Al-Fozan, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Upadhyay UD, Coplon L, Atrio JM, with the assistance of Margaret Villalonga and on behalf of the Society of Family Planning Clinical Affairs Committee. Society of Family Planning Committee Statement: Abortion nomenclature. Contraception 2023; 126:110094.</a></li><li><a class="nounderline abstract_t">Doubilet PM, Benson CB, Bourne T, et al. Diagnostic criteria for nonviable pregnancy early in the first trimester. N Engl J Med 2013; 369:1443.</a></li><li><a class="nounderline abstract_t">Dogra V, Paspulati RM, Bhatt S. First trimester bleeding evaluation. Ultrasound Q 2005; 21:69.</a></li><li class="breakAll">National Institute for Health and Clinical Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management. NICE Clinical Guideline 154. Manchester (UK): NICE; 2012. www.nice.org.uk/guidance/cg154 (Accessed on March 12, 2019).</li><li><a class="nounderline abstract_t">ACOG Practice Bulletin No. 200 Summary: Early Pregnancy Loss. Obstet Gynecol 2018; 132:1311.</a></li><li><a class="nounderline abstract_t">Kolte AM, Bernardi LA, Christiansen OB, et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod 2015; 30:495.</a></li><li><a class="nounderline abstract_t">Clement EG, Horvath S, McAllister A, et al. The Language of First-Trimester Nonviable Pregnancy: Patient-Reported Preferences and Clarity. Obstet Gynecol 2019; 133:149.</a></li><li><a class="nounderline abstract_t">ACOG Practice Bulletin No. 135: Second-trimester abortion. Obstet Gynecol 2013; 121:1394. Reaffirmed 2023.</a></li><li><a class="nounderline abstract_t">McPherson E. Recurrence of stillbirth and second trimester pregnancy loss. Am J Med Genet A 2016; 170A:1174.</a></li><li><a class="nounderline abstract_t">ACOG Practice Bulletin No. 102: management of stillbirth. Obstet Gynecol 2009; 113:748. Reaffirmed 2019.</a></li><li><a class="nounderline abstract_t">Magnus MC, Wilcox AJ, Morken NH, et al. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ 2019; 364:l869.</a></li><li><a class="nounderline abstract_t">Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319:189.</a></li><li><a class="nounderline abstract_t">Wyatt PR, Owolabi T, Meier C, Huang T. Age-specific risk of fetal loss observed in a second trimester serum screening population. Am J Obstet Gynecol 2005; 192:240.</a></li><li><a class="nounderline abstract_t">Nybo Andersen AM, Wohlfahrt J, Christens P, et al. Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320:1708.</a></li><li><a class="nounderline abstract_t">Slama R, Bouyer J, Windham G, et al. Influence of paternal age on the risk of spontaneous abortion. Am J Epidemiol 2005; 161:816.</a></li><li><a class="nounderline abstract_t">Woolner AMF, Raja EA, Bhattacharya S, et al. Inherited susceptibility to miscarriage: a nested case-control study of 31,565 women from an intergenerational cohort. Am J Obstet Gynecol 2020; 222:168.e1.</a></li><li><a class="nounderline abstract_t">Magnus MC, Morken NH, Wensaas KA, et al. Risk of miscarriage in women with chronic diseases in Norway: A registry linkage study. PLoS Med 2021; 18:e1003603.</a></li><li><a class="nounderline abstract_t">Giakoumelou S, Wheelhouse N, Cuschieri K, et al. The role of infection in miscarriage. Hum Reprod Update 2016; 22:116.</a></li><li><a class="nounderline abstract_t">Gomez GB, Kamb ML, Newman LM, et al. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ 2013; 91:217.</a></li><li><a class="nounderline abstract_t">Xiong YQ, Tan J, Liu YM, et al. The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: A systematic review and meta-analysis. J Clin Virol 2019; 114:12.</a></li><li><a class="nounderline abstract_t">Rasti S, Ghasemi FS, Abdoli A, et al. ToRCH "co-infections" are associated with increased risk of abortion in pregnant women. Congenit Anom (Kyoto) 2016; 56:73.</a></li><li><a class="nounderline abstract_t">Hoen B, Schaub B, Funk AL, et al. Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas. N Engl J Med 2018; 378:985.</a></li><li><a class="nounderline abstract_t">Ghasemi FS, Rasti S, Piroozmand A, et al. Toxoplasmosis-associated abortion and stillbirth in Tehran, Iran. J Matern Fetal Neonatal Med 2016; 29:248.</a></li><li><a class="nounderline abstract_t">Wedi CO, Kirtley S, Hopewell S, et al. Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. Lancet HIV 2016; 3:e33.</a></li><li><a class="nounderline abstract_t">Metwally M, Ong KJ, Ledger WL, Li TC. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril 2008; 90:714.</a></li><li><a class="nounderline abstract_t">Maraka S, Ospina NM, O'Keeffe DT, et al. Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. Thyroid 2016; 26:580.</a></li><li><a class="nounderline abstract_t">Li Y, Margerison-Zilko C, Strutz KL, Holzman C. Life Course Adversity and Prior Miscarriage in a Pregnancy Cohort. Womens Health Issues 2018; 28:232.</a></li><li><a class="nounderline abstract_t">Qu F, Wu Y, Zhu YH, et al. The association between psychological stress and miscarriage: A systematic review and meta-analysis. Sci Rep 2017; 7:1731.</a></li><li><a class="nounderline abstract_t">Frazier T, Hogue CJR, Bonney EA, et al. Weathering the storm; a review of pre-pregnancy stress and risk of spontaneous abortion. Psychoneuroendocrinology 2018; 92:142.</a></li><li><a class="nounderline abstract_t">Nepomnaschy PA, Welch KB, McConnell DS, et al. Cortisol levels and very early pregnancy loss in humans. Proc Natl Acad Sci U S A 2006; 103:3938.</a></li><li><a class="nounderline abstract_t">Wainstock T, Lerner-Geva L, Glasser S, et al. Prenatal stress and risk of spontaneous abortion. Psychosom Med 2013; 75:228.</a></li><li><a class="nounderline abstract_t">Bruckner TA, Mortensen LH, Catalano RA. Spontaneous Pregnancy Loss in Denmark Following Economic Downturns. Am J Epidemiol 2016; 183:701.</a></li><li><a class="nounderline abstract_t">Sastra C. Higher Cortisol Level Would Increase the Risk of Spontaneous Abortion. In J Obstet Gynecol 2013; 31.</a></li><li><a class="nounderline abstract_t">Ozgu-Erdinc AS, Tasdemir UG, Uygur D, et al. Outcome of intrauterine pregnancies with intrauterine device in place and effects of device location on prognosis. Contraception 2014; 89:426.</a></li><li><a class="nounderline abstract_t">Kasman AM, Zhang CA, Li S, et al. Association between preconception paternal health and pregnancy loss in the USA: an analysis of US claims data. Hum Reprod 2021; 36:785.</a></li><li><a class="nounderline abstract_t">Nakhai-Pour HR, Broy P, Sheehy O, Bérard A. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ 2011; 183:1713.</a></li><li><a class="nounderline abstract_t">Li DK, Ferber JR, Odouli R, Quesenberry C. Use of nonsteroidal antiinflammatory drugs during pregnancy and the risk of miscarriage. Am J Obstet Gynecol 2018; 219:275.e1.</a></li><li><a class="nounderline abstract_t">Yland JJ, Wesselink AK, Regan AK, et al. A prospective cohort study of preconception COVID-19 vaccination and miscarriage. Hum Reprod 2023; 38:2362.</a></li><li><a class="nounderline abstract_t">Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med 2021; 385:1536.</a></li><li><a class="nounderline abstract_t">Zauche LH, Wallace B, Smoots AN, et al. Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion. N Engl J Med 2021; 385:1533.</a></li><li><a class="nounderline abstract_t">Kharbanda EO, Haapala J, DeSilva M, et al. Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy. JAMA 2021; 326:1629.</a></li><li><a class="nounderline abstract_t">Avalos LA, Roberts SC, Kaskutas LA, et al. Volume and type of alcohol during early pregnancy and the risk of miscarriage. Subst Use Misuse 2014; 49:1437.</a></li><li><a class="nounderline abstract_t">Henriksen TB, Hjollund NH, Jensen TK, et al. Alcohol consumption at the time of conception and spontaneous abortion. Am J Epidemiol 2004; 160:661.</a></li><li><a class="nounderline abstract_t">Pineles BL, Park E, Samet JM. Systematic review and meta-analysis of miscarriage and maternal exposure to tobacco smoke during pregnancy. Am J Epidemiol 2014; 179:807.</a></li><li><a class="nounderline abstract_t">Ness RB, Grisso JA, Hirschinger N, et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 1999; 340:333.</a></li><li><a class="nounderline abstract_t">Chen LW, Wu Y, Neelakantan N, et al. Maternal caffeine intake during pregnancy and risk of pregnancy loss: a categorical and dose-response meta-analysis of prospective studies. Public Health Nutr 2016; 19:1233.</a></li><li><a class="nounderline abstract_t">Lee SW, Han YJ, Cho DH, et al. Smoking Exposure in Early Pregnancy and Adverse Pregnancy Outcomes: Usefulness of Urinary Tobacco-Specific Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Levels. Gynecol Obstet Invest 2018; 83:365.</a></li><li><a class="nounderline abstract_t">Sundermann AC, Zhao S, Young CL, et al. Alcohol Use in Pregnancy and Miscarriage: A Systematic Review and Meta-Analysis. Alcohol Clin Exp Res 2019; 43:1606.</a></li><li><a class="nounderline abstract_t">Yuan S, Liu J, Larsson SC. Smoking, alcohol and coffee consumption and pregnancy loss: a Mendelian randomization investigation. Fertil Steril 2021; 116:1061.</a></li><li><a class="nounderline abstract_t">Conner SN, Bedell V, Lipsey K, et al. Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysis. Obstet Gynecol 2016; 128:713.</a></li><li class="breakAll">Radiation and pregnancy: a fact sheet for clinicians. Centers for Disease Control and Prevention, 2014 https://emergency.cdc.gov/radiation/prenatalphysician.asp (Accessed on January 28, 2019).</li><li><a class="nounderline abstract_t">Rangel EL, Castillo-Angeles M, Easter SR, et al. Incidence of Infertility and Pregnancy Complications in US Female Surgeons. JAMA Surg 2021; 156:905.</a></li><li><a class="nounderline abstract_t">Mukherjee S, Velez Edwards DR, Baird DD, et al. Risk of miscarriage among black women and white women in a U.S. Prospective Cohort Study. Am J Epidemiol 2013; 177:1271.</a></li><li><a class="nounderline abstract_t">Oliver-Williams CT, Steer PJ. Racial variation in the number of spontaneous abortions before a first successful pregnancy, and effects on subsequent pregnancies. Int J Gynaecol Obstet 2015; 129:207.</a></li><li><a class="nounderline abstract_t">Pearlstone M, Baxi L. Subchorionic hematoma: a review. Obstet Gynecol Surv 1993; 48:65.</a></li><li><a class="nounderline abstract_t">Tuuli MG, Norman SM, Odibo AO, et al. Perinatal outcomes in women with subchorionic hematoma: a systematic review and meta-analysis. Obstet Gynecol 2011; 117:1205.</a></li><li><a class="nounderline abstract_t">Balogun OO, da Silva Lopes K, Ota E, et al. Vitamin supplementation for preventing miscarriage. Cochrane Database Syst Rev 2016; :CD004073.</a></li><li><a class="nounderline abstract_t">Gindler J, Li Z, Berry RJ, et al. Folic acid supplements during pregnancy and risk of miscarriage. Lancet 2001; 358:796.</a></li><li><a class="nounderline abstract_t">Gaskins AJ, Rich-Edwards JW, Hauser R, et al. Maternal prepregnancy folate intake and risk of spontaneous abortion and stillbirth. Obstet Gynecol 2014; 124:23.</a></li><li><a class="nounderline abstract_t">Coomarasamy A, Devall AJ, Cheed V, et al. A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy. N Engl J Med 2019; 380:1815.</a></li><li><a class="nounderline abstract_t">Cook R, Thomas V, Taft R, NIHR Dissemination Centre. Routine use of progesterone does not prevent miscarriage. BMJ 2019; 367:l5721.</a></li><li><a class="nounderline abstract_t">Coomarasamy A, Harb HM, Devall AJ, et al. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT. Health Technol Assess 2020; 24:1.</a></li><li><a class="nounderline abstract_t">Naimi AI, Perkins NJ, Sjaarda LA, et al. The Effect of Preconception-Initiated Low-Dose Aspirin on Human Chorionic Gonadotropin-Detected Pregnancy, Pregnancy Loss, and Live Birth : Per Protocol Analysis of a Randomized Trial. Ann Intern Med 2021; 174:595.</a></li><li class="breakAll">Hsu LYF. Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In: Genetic Disorders of the Fetus, 4th ed, Milunsky A (Ed), The Johns Hopkins University Press, Baltimore 1998. p.179.</li><li><a class="nounderline abstract_t">Levy B, Sigurjonsson S, Pettersen B, et al. Genomic imbalance in products of conception: single-nucleotide polymorphism chromosomal microarray analysis. Obstet Gynecol 2014; 124:202.</a></li><li><a class="nounderline abstract_t">Romero ST, Geiersbach KB, Paxton CN, et al. Differentiation of genetic abnormalities in early pregnancy loss. Ultrasound Obstet Gynecol 2015; 45:89.</a></li><li><a class="nounderline abstract_t">Soler A, Morales C, Mademont-Soler I, et al. Overview of Chromosome Abnormalities in First Trimester Miscarriages: A Series of 1,011 Consecutive Chorionic Villi Sample Karyotypes. Cytogenet Genome Res 2017; 152:81.</a></li><li><a class="nounderline abstract_t">Smits MAJ, van Maarle M, Hamer G, et al. Cytogenetic testing of pregnancy loss tissue: a meta-analysis. Reprod Biomed Online 2020; 40:867.</a></li><li><a class="nounderline abstract_t">Essers R, Lebedev IN, Kurg A, et al. Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss. Nat Med 2023; 29:3233.</a></li><li><a class="nounderline abstract_t">Schlaikjær Hartwig T, Ambye L, Gruhn JR, et al. Cell-free fetal DNA for genetic evaluation in Copenhagen Pregnancy Loss Study (COPL): a prospective cohort study. Lancet 2023; 401:762.</a></li><li><a class="nounderline abstract_t">Young BK. A multidisciplinary approach to pregnancy loss: the pregnancy loss prevention center. J Perinat Med 2018; 47:41.</a></li><li><a class="nounderline abstract_t">Sundermann AC, Velez Edwards DR, Bray MJ, et al. Leiomyomas in Pregnancy and Spontaneous Abortion: A Systematic Review and Meta-analysis. Obstet Gynecol 2017; 130:1065.</a></li><li><a class="nounderline abstract_t">Fanslow J, Silva M, Whitehead A, Robinson E. Pregnancy outcomes and intimate partner violence in New Zealand. Aust N Z J Obstet Gynaecol 2008; 48:391.</a></li><li><a class="nounderline abstract_t">Silverman JG, Gupta J, Decker MR, et al. Intimate partner violence and unwanted pregnancy, miscarriage, induced abortion, and stillbirth among a national sample of Bangladeshi women. BJOG 2007; 114:1246.</a></li><li><a class="nounderline abstract_t">Nur N. Association between domestic violence and miscarriage: a population-based cross-sectional study among women of childbearing ages, Sivas, Turkey. Women Health 2014; 54:425.</a></li><li><a class="nounderline abstract_t">Nelson DB, Grisso JA, Joffe MM, et al. Violence does not influence early pregnancy loss. Fertil Steril 2003; 80:1205.</a></li><li><a class="nounderline abstract_t">McNamee KM, Dawood F, Farquharson RG. Mid-trimester pregnancy loss. Obstet Gynecol Clin North Am 2014; 41:87.</a></li><li><a class="nounderline abstract_t">Allanson B, Jennings B, Jacques A, et al. Infection and fetal loss in the mid-second trimester of pregnancy. Aust N Z J Obstet Gynaecol 2010; 50:221.</a></li></ol></div><div id="topicVersionRevision">Topic 5439 Version 70.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37331458" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Society of Family Planning Committee Statement: Abortion nomenclature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24106937" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Diagnostic criteria for nonviable pregnancy early in the first trimester.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15905817" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : First trimester bleeding evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15905817" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : First trimester bleeding evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30629562" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : ACOG Practice Bulletin No. 200 Summary: Early Pregnancy Loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25376455" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30531561" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The Language of First-Trimester Nonviable Pregnancy: Patient-Reported Preferences and Clarity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23812485" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : ACOG Practice Bulletin No. 135: Second-trimester abortion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26945668" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Recurrence of stillbirth and second trimester pregnancy loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19300347" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : ACOG Practice Bulletin No. 102: management of stillbirth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30894356" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3393170" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Incidence of early loss of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15672031" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Age-specific risk of fetal loss observed in a second trimester serum screening population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10864550" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Maternal age and fetal loss: population based register linkage study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15840613" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Influence of paternal age on the risk of spontaneous abortion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31437424" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Inherited susceptibility to miscarriage: a nested case-control study of 31,565 women from an intergenerational cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33970911" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Risk of miscarriage in women with chronic diseases in Norway: A registry linkage study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26386469" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The role of infection in miscarriage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23476094" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30897374" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26499091" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : ToRCH "co-infections" are associated with increased risk of abortion in pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29539287" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25564725" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Toxoplasmosis-associated abortion and stillbirth in Tehran, Iran.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26762992" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18068166" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26837268" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29530382" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Life Course Adversity and Prior Miscarriage in a Pregnancy Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28496110" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The association between psychological stress and miscarriage: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29628283" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Weathering the storm; a review of pre-pregnancy stress and risk of spontaneous abortion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16495411" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Cortisol levels and very early pregnancy loss in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23362503" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Prenatal stress and risk of spontaneous abortion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27009344" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Spontaneous Pregnancy Loss in Denmark Following Economic Downturns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Higher Cortisol Level Would Increase the Risk of Spontaneous Abortion</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24508123" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Outcome of intrauterine pregnancies with intrauterine device in place and effects of device location on prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33336240" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Association between preconception paternal health and pregnancy loss in the USA: an analysis of US claims data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21896698" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29890124" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Use of nonsteroidal antiinflammatory drugs during pregnancy and the risk of miscarriage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37864485" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : A prospective cohort study of preconception COVID-19 vaccination and miscarriage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34496171" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34496196" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34495304" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24810392" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Volume and type of alcohol during early pregnancy and the risk of miscarriage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15383410" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Alcohol consumption at the time of conception and spontaneous abortion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24518810" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Systematic review and meta-analysis of miscarriage and maternal exposure to tobacco smoke during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9929522" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Cocaine and tobacco use and the risk of spontaneous abortion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26329421" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Maternal caffeine intake during pregnancy and risk of pregnancy loss: a categorical and dose-response meta-analysis of prospective studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29739005" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Smoking Exposure in Early Pregnancy and Adverse Pregnancy Outcomes: Usefulness of Urinary Tobacco-Specific Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31194258" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Alcohol Use in Pregnancy and Miscarriage: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34187701" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Smoking, alcohol and coffee consumption and pregnancy loss: a Mendelian randomization investigation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27607879" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27607879" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34319353" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Incidence of Infertility and Pregnancy Complications in US Female Surgeons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23558353" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Risk of miscarriage among black women and white women in a U.S. Prospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25799528" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Racial variation in the number of spontaneous abortions before a first successful pregnancy, and effects on subsequent pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8437776" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Subchorionic hematoma: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21508763" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Perinatal outcomes in women with subchorionic hematoma: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27150280" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Vitamin supplementation for preventing miscarriage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11564486" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Folic acid supplements during pregnancy and risk of miscarriage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24901281" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Maternal prepregnancy folate intake and risk of spontaneous abortion and stillbirth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31067371" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31704711" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Routine use of progesterone does not prevent miscarriage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32609084" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33493011" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The Effect of Preconception-Initiated Low-Dose Aspirin on Human Chorionic Gonadotropin-Detected Pregnancy, Pregnancy Loss, and Live Birth : Per Protocol Analysis of a Randomized Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33493011" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The Effect of Preconception-Initiated Low-Dose Aspirin on Human Chorionic Gonadotropin-Detected Pregnancy, Pregnancy Loss, and Live Birth : Per Protocol Analysis of a Randomized Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25004334" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Genomic imbalance in products of conception: single-nucleotide polymorphism chromosomal microarray analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25358469" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Differentiation of genetic abnormalities in early pregnancy loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28662500" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Overview of Chromosome Abnormalities in First Trimester Miscarriages: A Series of 1,011 Consecutive Chorionic Villi Sample Karyotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32417200" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Cytogenetic testing of pregnancy loss tissue: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37996709" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36739882" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Cell-free fetal DNA for genetic evaluation in Copenhagen Pregnancy Loss Study (COPL): a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29858908" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A multidisciplinary approach to pregnancy loss: the pregnancy loss prevention center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29016496" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Leiomyomas in Pregnancy and Spontaneous Abortion: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18837845" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Pregnancy outcomes and intimate partner violence in New Zealand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17877676" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Intimate partner violence and unwanted pregnancy, miscarriage, induced abortion, and stillbirth among a national sample of Bangladeshi women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24795047" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Association between domestic violence and miscarriage: a population-based cross-sectional study among women of childbearing ages, Sivas, Turkey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14607576" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Violence does not influence early pregnancy loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24491985" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Mid-trimester pregnancy loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20618237" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Infection and fetal loss in the mid-second trimester of pregnancy.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
